it is used in cosmetic formulations
When bound to these receptors, the action of GLP-1 antagonist has the following effects: Stimulates the production of insulin Reduces glucagon production in the liver Signals to the brain a feeling of fullness Slows the rate of gastric emptying This results in: Better regulation of blood sugar levels Reduction of appetite Reduction of food intake Weight loss In other words, patients get full quickly, stay full longer, and rarely have food cravings or hunger
En abril de 2026 , la agencia lo retir de esa Categora 2, junto a otros once pptidos, pero no porque mejorara su evidencia: los nominadores retiraron la candidatura
Making note of this, Novo Nordisk, the pharmaceutical company that makes Wegovy, began to test the medication's effectiveness as a weight-loss drug
Tirzepatide is FDA-approved (Mounjaro 2022, Zepbound 2023), but this specific combination with cagrilintide is not
If anecdotal evidence feels like a distraction to you, feel free to skip this section and jump to the research studies